532041 — Hindustan Bio Sciences Share Price
- IN₹80.88m
- IN₹102.34m
- IN₹10.53m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 9.55 | ||
Price to Tang. Book | 9.55 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 9.69 | ||
EV to EBITDA | 220.36 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 1.34% | ||
Return on Equity | 4.55% | ||
Operating Margin | 5.12% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | n/a | n/a | n/a | 9.22 | 10.53 | n/a | n/a | 14.15% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Hindustan Bio Sciences Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical products. The Company is involved in the trading of drugs and medicine. The Company has manufacturing facilities for dry and liquid injectables, liquid/dry syrups, eye/ear/nasal drops, pre-filled syringes and non-sterile/sterile ointments, tablets, and capsules. Its products include tablets, capsules, drops, externels, and syrups.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 16th, 1991
- Public Since
- July 7th, 2005
- No. of Employees
- 3
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Bombay Stock Exchange
- Shares in Issue
- 10,250,800

- Address
- H.No: 8-2-269/S, HYDERABAD, 500034
- Web
- https://www.hindustanbiosciences.in/
- Phone
- +91 4023555181
- Contact
- Venkata Rama Raju Jampana
- Auditors
- M/s. VASG & Associates
Upcoming Events for 532041
Q1 2026 Hindustan Bio Sciences Ltd Earnings Release
Hindustan Bio Sciences Ltd Annual Shareholders Meeting
Similar to 532041
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
As of Today at 21:06 UTC, shares in Hindustan Bio Sciences are trading at IN₹7.79. This share price information is delayed by 15 minutes.
Shares in Hindustan Bio Sciences last closed at IN₹7.79 and the price had moved by -10.36% over the past 365 days. In terms of relative price strength the Hindustan Bio Sciences share price has underperformed the S&P BSE 100 Index by -15.55% over the past year.
There is no consensus recommendation for this security.
Find out moreHindustan Bio Sciences does not currently pay a dividend.
Hindustan Bio Sciences does not currently pay a dividend.
Hindustan Bio Sciences does not currently pay a dividend.
To buy shares in Hindustan Bio Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹7.79, shares in Hindustan Bio Sciences had a market capitalisation of IN₹80.88m.
Here are the trading details for Hindustan Bio Sciences:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 532041
Based on an overall assessment of its quality, value and momentum Hindustan Bio Sciences is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hindustan Bio Sciences. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -34.58%.
As of the last closing price of IN₹7.79, shares in Hindustan Bio Sciences were trading -14.32% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hindustan Bio Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹7.79.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Hindustan Bio Sciences' directors